Find clinical trials in your area

Search by disease and location to discover available clinical trials matching your criteria.

Matched clinical trials

  • Study of zolbetuximab, pembrolizumab and chemotherapy in adults with HER2-negative, Claudin 18.

    Not recruiting

    1 1 1
    Investigated diseases:
    Belgium Czechia France Germany Italy Lithuania +5
  • Study of rilvegostomig, trastuzumab deruxtecan, and AZD0901 in patients with locally advanced resectable gastroesophageal cancer before and after surgery

    Not recruiting

    1 1
    Investigated diseases:
    Italy Spain
  • Study on Reducing Chemotherapy for Patients with Low-Risk Localized Gastroesophageal Cancer Using Docetaxel, Oxaliplatin, Calcium Folinate, and Fluorouracil

    Not recruiting

    1 1 1
    Investigated diseases:
    France
  • Study on the Effectiveness and Safety of AZD0901 Compared to Standard Treatments for Adults with Advanced Gastric or Gastroesophageal Junction Cancer Expressing Claudin 18.2

    Not recruiting

    1 1 1 1
    France Germany Italy Poland Spain
  • Study on Organ Preservation for Early Stage Esophageal Cancer Using Durvalumab and Chemoradiation for Patients Eligible for Surgery

    Not recruiting

    1 1 1
    Germany
  • Study of Zanidatamab and Tislelizumab Combined with Chemotherapy for Patients with Advanced or Metastatic HER2-positive Gastroesophageal Cancer

    Not recruiting

    1 1 1 1
    Belgium Estonia France Germany Greece Ireland +6
  • Study Comparing Ramucirumab with Irinotecan, Leucovorin, and 5-FU or Paclitaxel for Patients with Advanced Stomach or Gastroesophageal Cancer After Previous Chemotherapy

    Not recruiting

    1 1 1 1
    Austria Germany Italy
  • Study comparing chemotherapy with or without radiation therapy in patients with resectable gastroesophageal junction cancer using docetaxel, oxaliplatin, fluorouracil and calcium folinate

    Not recruiting

    1 1 1 1
    Investigated diseases:
    Germany
  • Study on Durvalumab and FLOT Chemotherapy for Patients with Resectable Gastric and Gastroesophageal Cancer

    Not recruiting

    1 1 1
    Investigated diseases:
    Belgium Denmark France Germany Hungary The Netherlands +2
  • Study on Tocilizumab for Patients with Esophageal Cancer to Improve Chemoradiotherapy Outcomes

    Not recruiting

    1 1 1
    Investigated drugs:
    The Netherlands